Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects

NCT01861626 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: V0057 - A mg
DRUG: Isotretinoin

Sponsor

Pierre Fabre Dermatology